Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP401375.RASJSWg5RC3Bhu1myppNmacIj7EirUtawa6kuMc5c4rZs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP401375.RASJSWg5RC3Bhu1myppNmacIj7EirUtawa6kuMc5c4rZs130_assertion type Assertion NP401375.RASJSWg5RC3Bhu1myppNmacIj7EirUtawa6kuMc5c4rZs130_head.
- NP401375.RASJSWg5RC3Bhu1myppNmacIj7EirUtawa6kuMc5c4rZs130_assertion description "[The recent identification in transitional cell carcinoma of mutations in a fibroblast growth factor (FGF) receptor, namely FGF receptor-3, has provoked great interest in the potential usefulness of FGF receptors and their ligands as molecular markers and as targets for bladder cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP401375.RASJSWg5RC3Bhu1myppNmacIj7EirUtawa6kuMc5c4rZs130_provenance.
- NP401375.RASJSWg5RC3Bhu1myppNmacIj7EirUtawa6kuMc5c4rZs130_assertion evidence source_evidence_literature NP401375.RASJSWg5RC3Bhu1myppNmacIj7EirUtawa6kuMc5c4rZs130_provenance.
- NP401375.RASJSWg5RC3Bhu1myppNmacIj7EirUtawa6kuMc5c4rZs130_assertion SIO_000772 12544341 NP401375.RASJSWg5RC3Bhu1myppNmacIj7EirUtawa6kuMc5c4rZs130_provenance.
- NP401375.RASJSWg5RC3Bhu1myppNmacIj7EirUtawa6kuMc5c4rZs130_assertion wasDerivedFrom befree-20150227 NP401375.RASJSWg5RC3Bhu1myppNmacIj7EirUtawa6kuMc5c4rZs130_provenance.
- NP401375.RASJSWg5RC3Bhu1myppNmacIj7EirUtawa6kuMc5c4rZs130_assertion wasGeneratedBy ECO_0000203 NP401375.RASJSWg5RC3Bhu1myppNmacIj7EirUtawa6kuMc5c4rZs130_provenance.